References
- US Food and Drug Administration. International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use; availability. Notice. Fed Regist. 2012;77(110):33748–33749.
- Bhuyan BK, Zimmer DM, Mazurek JH, et al. Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents. Cancer Res. 1983;43(11):5293–5297.
- Brambilla G, Martelli A. Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics. Pharmacol Res. 2009;60(1):1–17.
- Brambilla G, Mattioli F, Robbiano L, Martelli A. Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs. Mutagenesis. 2012;27(4):387–413.
- Chakravarthy S, Sadagopan S, Nair A, Sukumaran SK. Zebrafish as an in vivo high-throughput model for genotoxicity. Zebrafish. 2014;11(2):154–166.
- Ames BN, Lee FD, Durston WE. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci U S A. 1973;70(3):782–786.
- Ames BN, Durston WE, Yamasaki E, Lee FD. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A. 1973; 70(8):2281–2285.
- McMahon RE, Cline JC, Thompson CZ. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens. Cancer Res. 1979;39(3):682–693.
- Bridges BA. The fluctuation test. Arch Toxicol. 1980;46(1–2):41–44.
- Cerep. Genotoxicity. 2013. Available from: http://www.cerep.fr/cerep/users/pages/Downloads/Documents/Marketing/Pharmacology%20&%20ADME/Application%20notes/Genotoxicity.pdf. Accessed November 4, 2015.
- Gentronix. Ames MPF. Available from: http://www.gentronix.co.uk/product/ames-mpf. Accessed November 4, 2015.
- Guadaño A, de la Peña E, González-Coloma A, Alvarez JF. Development of a new bioluminescent mutagenicity assay based on the Ames test. Mutagenesis. 1999;14(4):411–415.
- Aubrecht J, Osowski JJ, Persaud P, et al. Bioluminescent Salmonella reverse mutation assay: a screen for detecting mutagenicity with high throughput attributes. Mutagenesis. 2007;22(5):335–342.
- Ruiz-Vázquez R, Pueyo C, Cerdá-Olmedo E. A mutagen assay detecting forward mutations in an arabinose-sensitive strain of Salmonella typhimurium. Mutat Res. 1978;54(2):121–129.
- Quillardet P, Huisman O, D’Ari R, Hofnung M. SOS chromotest, a direct assay of induction of an SOS function in Escherichia coli K-12 to measure genotoxicity. Proc Natl Acad Sci U S A. 1982;79(19):5971–5975.
- Biran A, Ben Yoav H, Yagur-Kroll S, et al. Microbial genotoxicity bioreporters based on sulA activation. Anal Bioanal Chem. 2011; 400(9):3013–3024.
- Musgrove C, Camps M. . Models for detection of genotoxicity in vivo: present and future. In: Mishra DR, editor. Mutagenesis. Rijeka, Croatia: InTech; 2012:31–50.
- Hontzeas N, Hafer K, Schiestl RH. Development of a microtiter plate version of the yeast DEL assay amenable to high-throughput toxicity screening of chemical libraries. Mutat Res. 2007;634(1–2):228–234.
- Knight AW, Birrell L, Walmsley RM. Development and validation of a higher throughput screening approach to genotoxicity testing using the GADD45a-GFP GreenScreen HC assay. J Biomol Screen. 2009; 14(1):16–30.
- Tice RR, Agurell E, Anderson D, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000;35(3):206–221.
- Burlinson B. The in vitro and in vivo comet assays. Methods Mol Biol. 2012;817:143–163.
- Organisation for Economic Co-operation and Development. OECD guideline for the testing of chemicals: In vivo mammalian alkaline comet assay. 2014. Available from: http://www.oecd-ilibrary.org/docserver/download/9714511e.pdf?expires=1446582965&id=id&accname=guest&checksum=E9C03B8F9287629EB00C9CA8C5EF2643. Accessed November 4, 2015.
- Liao W, McNutt MA, Zhu WG. The comet assay: a sensitive method for detecting DNA damage in individual cells. Methods. 2009;48(1):46–53.
- Brendler-Schwaab S, Hartmann A, Pfuhler S, Speit G. The in vivo comet assay: use and status in genotoxicity testing. Mutagenesis. 2005;20(4):245–254.
- Kiskinis E, Suter W, Hartmann A. High throughput comet assay using 96-well plates. Mutagenesis. 2002;17(1):37–43.
- Gentronix. Comet assay. Available from: http://www.gentronix.co.uk/product/comet-assay. Accessed November 4, 2015.
- Ge J, Prasongtanakij S, Wood DK, et al. CometChip: a high-throughput 96-well platform for measuring DNA damage in microarrayed human cells. J Vis Exp. 2012;(92):e50607.
- Organisation for Economic Co-operation and Development. OECD guideline for testing of chemicals: Mammalian erythrocyte micronucleus test. 1997. Available from: http://www.oecd.org/chemicalsafety/risk-assessment/1948442.pdf. Accessed November 4, 2015.
- Organisation for Economic Co-operation and Development. OECD guidelines for testing of chemicals: Proposal for updating test guideline 487 – In vitro mammalian cell micronucleus test. 2012. Available from: http://www.oecd.org/env/ehs/testing/TG487%20Oct%202012%20updated%2029oct.pdf. Accessed November 4, 2015.
- Kirsch-Volders M, Decordier I, Elhajouji A, Plas G, Aardema MJ, Fenech M. In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models. Mutagenesis. 2011;26(1):177–184.
- Gentronix. In vitro mammalian cell micronucleus test (OECD 487). Available from: http://www.gentronix.co.uk/product/micronucleus-test. Accessed November 4, 2015.
- Diaz D, Scott A, Carmichael P, Shi W, Costales C. Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. Mutat Res. 2007;630(1–2):1–13.
- Lloyd M, Kidd D. The mouse lymphoma assay. Methods Mol Biol. 2012;817:35–54.
- Clive D, Johnson KO, Spector JF, Batson AG, Brown NM. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. Mutat Res. 1979;59(1):61–108.
- Honma M, Hayashi M, Shimada H, et al. Evaluation of the mouse lymphoma TK assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis. 1999;14(1):5–22.
- Howe K, Clark MD, Torroja CF, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496(7446):498–503.
- [No authors listed]. Directive 2010/63/EU of the European Parliament and the Council of 22 September 2010 on the protection of animals used for scientific purposes. OJEU. 2010;276:33–79.
- Siddique HR, Chowdhuri DK, Saxena DK, Dhawan A. Validation of Drosophila melanogaster as an in vivo model for genotoxicity assessment using modified alkaline comet assay. Mutagenesis. 2005; 20(4):285–290.
- Meier B, Gartner A. Having a direct look: analysis of DNA damage and repair mechanisms by next generation sequencing. Exp Cell Res. 2014;329(1):35–41.
- National Toxicology Program. Tox21. Available from: http://ntp.niehs.nih.gov/results/hts/index.html. Accessed November 4, 2015.
- Lee MY, Kumar RA, Sukumaran SM, Hogg MG, Clark DS, Dordick JS. Three-dimensional cellular microarray for high-throughput toxicology assays. Proc Natl Acad Sci U S A. 2008;105(1):59–63.
- Fernandes TG, Diogo MM, Clark DS, Dordick JS, Cabral JM. High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. Trends Biotechnol. 2009;27(6):342–349.
- Powell JR, Bennett MR, Evans KE, et al. 3D-DIP-Chip: a microarray-based method to measure genomic DNA damage. Sci Rep. 2015; 5:7975.
- High Content Toxicology: CellCiphr® Premier. Available from: http://www.cyprotex.com/toxicology/multiparametric/cellciphr-premier/. Accessed November 4, 2015.
- Thermo Fisher Scientific. CellSensor® p53RE-bla HCT-116 cell line. Available from: https://www.thermofisher.com/order/catalog/product/K1640. Accessed November 4, 2015.
- SABiosciences. Oligo GEArray® human DNA damage signaling pathway microarray. Available from: http://saweb2.sabiosciences.com/gene_array_product/HTML/OHS-029.html. Accessed November 4, 2015.
- Simpson K, Bevan N, Hastwell P, et al. The BlueScreen-384 assay as an indicator of genotoxic hazard potential in early-stage drug discovery. J Biomol Screen. 2013;18(4):441–452.
- Fox JT, Myung K. Cell-based high-throughput screens for the discovery of chemotherapeutic agents. Oncotarget. 2012;3(5):581–585.
- Rajakrishna L, Unni SK, Subbiah M, et al. Validation of a human cell based high-throughput genotoxicity assay ‘Anthem’s Genotoxicity screen’ using ECVAM recommended lists of genotoxic and non-genotoxic chemicals. Toxicol In Vitro. 2014;28(1):46–53.